1v1t: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1v1t.png|left|200px]] | [[Image:1v1t.png|left|200px]] | ||
| Line 10: | Line 9: | ||
{{STRUCTURE_1v1t| PDB=1v1t | SCENE= }} | {{STRUCTURE_1v1t| PDB=1v1t | SCENE= }} | ||
=== | ===Crystal structure of the PDZ tandem of human syntenin with TNEYKV peptide=== | ||
| Line 20: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
[[1v1t]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1V1T OCA]. | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:016533050</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Cierpicki, T.]] | [[Category: Cierpicki, T.]] | ||
[[Category: Cooper, D.]] | [[Category: Cooper, D R.]] | ||
[[Category: Derewenda, U.]] | [[Category: Derewenda, U.]] | ||
[[Category: Derewenda, Z S.]] | [[Category: Derewenda, Z S.]] | ||
[[Category: Devedjiev, Y.]] | [[Category: Devedjiev, Y.]] | ||
[[Category: Grembecka, J.]] | [[Category: Grembecka, J.]] | ||
[[Category: Adhesion-complex]] | |||
[[Category: Cell adhesion]] | |||
[[Category: Pdz domain]] | [[Category: Pdz domain]] | ||
[[Category: Scaffolding protein]] | [[Category: Scaffolding protein]] | ||
Revision as of 08:06, 30 May 2012
Crystal structure of the PDZ tandem of human syntenin with TNEYKV peptideCrystal structure of the PDZ tandem of human syntenin with TNEYKV peptide
Template:ABSTRACT PUBMED 16533050
About this StructureAbout this Structure
1v1t is a 4 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Grembecka J, Cierpicki T, Devedjiev Y, Derewenda U, Kang BS, Bushweller JH, Derewenda ZS. The binding of the PDZ tandem of syntenin to target proteins. Biochemistry. 2006 Mar 21;45(11):3674-83. PMID:16533050 doi:10.1021/bi052225y